"Endemic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children (malaria in many communities is a holoendemic disease). A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. (Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80)
| Descriptor ID |
D019353
|
| MeSH Number(s) |
N06.850.392
|
| Concept/Terms |
Endemic Diseases- Endemic Diseases
- Disease, Endemic
- Diseases, Endemic
- Endemic Disease
|
Below are MeSH descriptors whose meaning is more general than "Endemic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Endemic Diseases".
This graph shows the total number of publications written about "Endemic Diseases" by people in this website by year, and whether "Endemic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endemic Diseases" by people in Profiles.
-
Diptyanusa A, Zablon KN. Addressing budget reduction and reallocation on health-related resources during COVID-19 pandemic in malaria-endemic countries. Malar J. 2020 Nov 16; 19(1):411.
-
Maulden AB, Garro AC, Balamuth F, Levas MN, Bennett JE, Neville DN, Branda JA, Nigrovic LE. Two-Tier Lyme Disease Serology Test Results Can Vary According to the Specific First-Tier Test Used. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):128-133.
-
Gluckman SJ. Acute respiratory infections in a recently arrived traveler to your part of the world. Chest. 2008 Jul; 134(1):163-71.
-
Jabeen K, Zafar A, Hasan R. Increased isolation of Vibrio cholerae O1 serotype Inaba over serotype Ogawa in Pakistan. East Mediterr Health J. 2008 May-Jun; 14(3):564-70.
-
Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Am J Trop Med Hyg. 2007 Oct; 77(4):640-6.
-
Gilani JM, Khan OA. Concerns with travel medicine article. Del Med J. 2007 Aug; 79(8):323-4; author reply 325.
-
Avery RA, Frank G, Glutting JJ, Eppes SC. Prediction of Lyme meningitis in children from a Lyme disease-endemic region: a logistic-regression model using history, physical, and laboratory findings. Pediatrics. 2006 Jan; 117(1):e1-7.